Bioterrorism
Biotechnology Industry Organization applauds Senate passage of BARDA legislation
Published in Biotech Law Weekly, January 5th, 2007
"Passage by the U.S. Senate of this bill, which includes critical BARDA provisions and provisions to reauthorize bioterrorism grants, is an important and necessary step toward improving America's defenses against bioterrorism and pandemic diseases.
"This legislation recognizes that the 'Valley of Death' remains a barrier to effective countermeasure product development, and authorizes the Biomedical Advanced Research and Development Authority (BARDA) within...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2007-01-05)
More Articles from Biotech Law Weekly
- Diet & Nutrition
Commercial marketing in schools may discourage healthy nutrition environment for students - Environmental Health
Study reveals air pollution is a health threat in major Asian cities - Finance
ImmuneRegen BioSciences closes round of funding - Finance
Lifestream Technologies files for Chapter 11 protection, takes action to sell assets - Finance
Merck reaffirms full-year 2006 EPS guidance, 2007 EPS growth excluding restructuring charges - Healthcare Policy
Combating Autism Act passes House of Representatives by two-thirds majority - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
